Broward Oncology Associates

Fort Lauderdale, Florida 33308-1414

0 studies enrolling now · 16 studies all time

What they study most

Adult Solid Tumor, Chronic Myeloid Leukemia, Clear Cell Renal Carcinoma, Colorectal Neoplasms, Diffuse Large-Cell Lymphoma, Gastric Cancer, Leukemia, Myelogenous, Chronic, Lung Cancer, NSCLC, Non Small Cell Lung Carcinoma, Non-small Cell Lung Cancer, Pancreatic Cancer

Studies at this site

• A Safety and Efficacy Study in Patients With Gastric Cancer — Completed
• A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin — Completed
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer — Completed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• TroVax Renal Immunotherapy Survival Trial — Completed
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Stopped early
• Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) — Completed
• CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 — Paused
• Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer — Completed
• Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer — Stopped early
• Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early